Influenza Surveillance in Russia Based on Epidemiological and Laboratory Data for the Period From 2005 to 2012

Anna, Sominina; Burtseva, Elena; Eropkin, M. Yu.; Карпова, Л. С.; Zarubaev, Vladimir V.; Smorodintseva, Elizaveta; Коновалова, Н. И.; Danilenko, Daria; Prokopetz, A. V.; Grudinin, Mikhail; Pisareva, Maria; Anfimov, Pavel; Stolyarov, Kirill; Киселев, О. И.; Shevchenko, Ekaterina S.; Ivanova, Valeriya; Трушакова, С. В.; Breslav, Nataliya; L'vov, D K; Klimov, Alexander; Moen, Ann; Cox, Nancy J.

doi:10.3844/ajidsp.2013.77.93

Cited by 19 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite multiple single-site or national surveillance data for influenza and/or RSV being available either via publication or online, e.g. from Argentina, 9 Brazil, 10 Canada, 11 UK, 12 The Netherlands, 13 Finland, 14 Bulgaria, 15 Russia, 16 South Africa, 17 Rwanda, 18 Madagascar, 19 Cambodia, 20 Thailand, 21 Malaysia, 22 Singapore, 23 The Philippines, 24 Indonesia, 25 Hong Kong, 26 Mongolia, 27 Japan, 28 Australia, 29 and New Zealand, 30 there are still relatively few global-scale studies that compare the contemporaneous (i.e. over the same time period) incidence patterns of common respiratory viruses across different countries -and nearly all of these used mostly publicly available surveillance data extracted from national surveillance websites, or published studies.…”

Section: Introductionmentioning

confidence: 99%

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015

Lam

Tang

Lai

et al. 2019

Journal of Infection

View full text Add to dashboard Cite

s u m m a r yObjectives: To improve our understanding of the global epidemiology of common respiratory viruses by analysing their contemporaneous incidence at multiple sites. Methods: 2010-2015 incidence data for influenza A (IAV), influenza B (IBV), respiratory syncytial (RSV) and parainfluenza (PIV) virus infections were collected from 18 sites (14 countries), consisting of local ( n = 6), regional ( n = 9) and national ( n = 3) laboratories using molecular diagnostic methods. Each site submitted monthly virus incidence data, together with details of their patient populations tested and diagnostic assays used.Results: For the Northern Hemisphere temperate countries, the IAV, IBV and RSV incidence peaks were 2-6 months out of phase with those in the Southern Hemisphere, with IAV having a sharp out-of-phase difference at 6 months, whereas IBV and RSV showed more variable out-of-phase differences of 2-6 months. The tropical sites Singapore and Kuala Lumpur showed fluctuating incidence of these viruses throughout the year, whereas subtropical sites such as Hong Kong, Brisbane and Sydney showed distinctive biannual peaks for IAV but not for RSV and PIV. Conclusions: There was a notable pattern of synchrony of IAV, IBV and RSV incidence peaks globally, and within countries with multiple sampling sites (Canada, UK, Australia), despite significant distances between these sites.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015

Lam

Tang

Lai

et al. 2019

Journal of Infection

View full text Add to dashboard Cite

show abstract

“…There is also no evidence of naturally occurring resistance to umifenovir in any influenza virus isolates. 17,18 On August 10, 2010, the WHO declared a worldwide postpandemic period. Similar to most other countries, the peak influenza season during 2010-2011 in Russia was associated with the co-circulation of three influenza viruses: A(H1N1)pdm09, A(H3N2), and B.…”

Section: Introductionmentioning

confidence: 99%

“…A detailed study of the epidemic antigenic properties of the strains showed that most of the strains were similar to the reference strains that were recommended for vaccine composition for the 2010-2011 epidemic season, which included A/California/07/2009 (H1N1)pdm09, A/Perth/16/2009 A(H3N2), and B/Brisbane/60/2008 (8.0% of strains were similar to another evolutionary line, B/Yamagata/16/88). 17,18 The purpose of this study was to provide detailed information regarding virus susceptibility and clinical effectiveness in a retrospective pharmacoepidemiological study of oseltamivir and umifenovir, which were licensed and used widely during the first post-pandemic 2010-2011 influenza season in Russia. The experimental part of this study aimed to make recommendations for the treatment and prophylaxis of influenza viruses that circulated during this period, including the swine influenza A(H1N1) virus.…”

Section: Introductionmentioning

confidence: 99%

Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia

Ленева

Burtseva

Yatsyshina

et al. 2016

International Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Это, в свою очередь, позволит выиграть время, необходимое для наработки вакцин из ново-го возбудителя, оценки его чувствительности к противовирусным препаратам и в конечном итоге -снизить заболеваемость и смертность от гриппа. Контроль за состоянием популяци-онного иммунитета к сезонным и потенциаль-но пандемическим вирусам гриппа является важным звеном надзора и раннего распозна-вания начала циркуляции нового возбудителя [10]. Сказанное определяет важность продол-жения работ в указанном направлении.…”

Section: Discussionunclassified

POPULATION IMMUNITY TO INFLUENZA VIRUS A(H1N1)pdm09, A(H3N2) AND B IN THE ADULT POPULATION OF THE RUSSIAN FEDERATION LONG-TERM RESEARCH RESULTS

Коншина

Соминина

Smorodintseva

et al. 2017

Russian Journal of Infection and Immunity

View full text Add to dashboard Cite

Резюме. Проведен анализ изменений уровня популяционного иммунитета трудоспособного взрослого населе-ния более 20 городов России, сотрудничающих с Федеральным центром по гриппу, к циркулирующим вирусам гриппа A(H1N1)pdm09, A(H3N2) и B в период с 2009 по 2015 гг. К началу пандемии (октябрь 2009 г.) населе-ние России было практически серонегативным к вируcу гриппа A(H1N1)pdm09. После первой волны пандемии средние геометрические титры антител (СГТ АТ) к возбудителю пандемии повысились в 2,6 раза, после вто-рой -в 4,9 раза по сравнению с исходным уровнем (1:5,5), далее наблюдалось последовательное нарастание СГТ АТ после каждого из последующих сезонов активной циркуляции пандемического вируса, достигнув максиму-ма (1:41) к апрелю 2013 г., после очередной эпидемии, вызванной этим вирусом. Доля лиц с защитными титрами антител (ЗТА) к уже начавшему циркулировать вирусу гриппа А(H1N1)pdm09 в октябре 2009 г. составила 8,2%, к вирусу А(H3N2) -58,3%, и к вирусу В -59,7%. Уровень популяционного иммунитета у взрослых к возбудите-лям сезонных эпидемий -вирусам гриппа A(H3N2) и В и в дальнейшем, на протяжении всего наблюдаемого периода, был достоверно выше, чем к вирусу гриппа A(H1N1)pdm09. Процент лиц с ЗТА к вирусам А(H3N2) и В в указанный период варьировал для вируса А(H3N2) в пределах от 58,3 до 75,5%, для вируса гриппа В -от 59,7 до 82,3%. Соответственно, показатели заболеваемости взрослого населения в эпидемии гриппа, вызванные эти-ми возбудителями были ниже, чем в эпидемии, связанные с активной циркуляцией вируса A(H1N1)pdm09. По-лученные данные служат одним из оснований для составления прогнозов развития заболеваемости гриппом в предстоящий эпидемический сезон и соответствующих рекомендаций по защите населения от гриппа. POPULATION IMMUNITY TO INFLUENZA VIRUS A(H1N1)pdm09, A(H3N2) AND B IN THE ADULT POPULATION OF THE RUSSIAN FEDERATION LONG-TERM RESEARCH RESULTS Konshina

show abstract

Influenza Surveillance in Russia Based on Epidemiological and Laboratory Data for the Period From 2005 to 2012

Cited by 19 publications

References 7 publications

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015

Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia

POPULATION IMMUNITY TO INFLUENZA VIRUS A(H1N1)pdm09, A(H3N2) AND B IN THE ADULT POPULATION OF THE RUSSIAN FEDERATION LONG-TERM RESEARCH RESULTS

Contact Info

Product

Resources

About